Product and Service Showcases Keep You Up to Speed

Don’t miss the Product Showcase Tuesday the Exhibit Hall. These educational and product-oriented sessions provide you with an in-depth presentation on a product or service you may have seen in the Exhibit Hall. Show up early—seating is limited to 150, and a boxed meal will be served at each event.

Tuesday

BMS/Pfizer Showcase

Treatment of VTE and Reduction in the Risk of Recurrent VTE Following Initial Therapy

11:30 a.m.–12:15 p.m.
Product Showcase I
Speaker: Robert Dunne, MD
This session will preview clinical trial information that led to the U.S. Food and Drug Administration approval of Apixaban for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and risk of recurrent DVT/PE following initial therapy. Both AMPLIFY and AMPLIFY-Extend efficacy and safety data will be discussed, with time allocated throughout the presentation for questions.

Portola Pharmaceuticals, Inc. Showcase

In-Hospital to Home: New Standards for Extended-Duration VTE Prophylaxis in Acutely Ill Medical Patients

11:30 a.m.–12:15 p.m.
Product Showcase II
Speaker: Marc Cohen, MD, FACC
Please join us for a product showcase sponsored by Portola Pharmaceuticals. This program will review the burden of VTE in acutely ill medical patients, provide an overview of the unmet need for extended-duration VTE prophylaxis from in-hospital to home, and review the APEX clinical trial data.

AcelRX Showcase

Frontline Therapy: A New Approach to ED Pain Management

2:30–3:15 p.m.
Product Showcase I
Speakers: James Miner, MD, and Pamela Palmer, MD, PhD
Establishing IV access in a busy emergency department can be challenging, time consuming, and resource intensive, especially when the patient has difficult IV access. When the patient is also suffering from moderate-to-severe acute pain, this delay in analgesic administration can cause significant anxiety and needless suffering. Our faculty will discuss a new approach to pain management that alleviates the challenges with IV access and potentially addresses unmet needs regarding management of acute pain in the emergency department setting. Safety and efficacy data from clinical trials, including patients presenting to the emergency department with moderate-to-severe acute pain, will be reviewed.

Janssen Pharmaceuticals Showcase

Clinical Data and Real-World Evidence to Support DVT/PE Treatment Decision Making

2:30–3:15 p.m.
Product Showcase II
Speaker: James Neuenschwande, MD
This lecture will discuss treatment options for patients with DVT and PE and how they can reduce the risk of recurrent thrombotic events. This promotional educational activity is not accredited. The program content is developed by Janssen Pharmaceuticals, Inc. Speakers present on behalf of the company and are required to present information in compliance with FDA requirements for communications about its medicines.